Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSorafenib targets BCR kinases and blocks migratory and microenvironmental survival signals in CLL cells.AuthorsLópez-Guerra, M; Xargay-Torrent, S; Pérez-Galán, P; Saborit-Villarroya, I; Rosich, L; Villamor, N; Aymerich, M; Roué, G; Campo, E; Montserrat, E; Colomer, DAbstractA letter to the editor is presented regarding the efficacy of multikinase inhibitor sorafenib in targeting B-cell receptor (BCR) kinases and blocking migratory and microenvironmental survival signals in chronic lymphocytic leukemia (CLL) cells.SubjectsLETTERS to the editor; KINASE inhibitors; CHRONIC lymphocytic leukemiaPublicationLeukemia (08876924), 2012, Vol 26, Issue 6, p1429ISSN0887-6924Publication typeArticleDOI10.1038/leu.2011.364